Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04418167
Title JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations
Recruitment Suspended
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors JS InnoPharm, LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Cancer Center Phoenix Arizona 85054 United States Details
University of Arizona Comprehensive Cancer Center Tucson Arizona 85724 United States Details
University of California Helen Diller Family Comprehensive Cancer Center San Francisco California 94158 United States Details
Mayo Clinic Cancer Center Jacksonville Florida 32224 United States Details
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Mayo Clinic Cancer Center Rochester Minnesota 55905 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field